There was no significant between-group difference in the rate of the composite primary end point ( @ patients -LSB- @ % -RSB- in the RIPC group and @ -LSB- @ % -RSB- in the sham-RIPC group , P = @ ) or of any of the individual components : death ( @ patients -LSB- @ % -RSB- and @ -LSB- @ % -RSB- , respectively ; P = @ ) , myocardial infarction ( @ -LSB- @ % -RSB- and @ -LSB- @ % -RSB- , P = @ ) , stroke ( @ -LSB- @ % -RSB- and @ -LSB- @ % -RSB- , P = @ ) , and acute renal failure ( @ -LSB- @ % -RSB- and @ -LSB- @ % -RSB- , P = @ ) .